Endocrinology • Fertility • Reproductive Hormones • Laboratory Interpretation
Prepared by:
Omar Adwan — DHA-Licensed Medical Laboratory Technologist | Founder, MedLab Academy
Last reviewed and evidence checked: September 22, 2026
Anti-Müllerian hormone, or AMH, is a hormone produced mainly by granulosa cells in small developing ovarian follicles. In reproductive-age women, AMH is widely used as a laboratory marker of ovarian reserve and can help predict how the ovaries may respond to fertility stimulation.
A low AMH generally suggests a smaller remaining pool of recruitable follicles, while a higher AMH is often associated with a larger follicle pool and may be seen in women with polycystic ovarian morphology or PCOS.
However, AMH does not measure egg quality, does not determine whether pregnancy is possible, and should not be interpreted as a fertility “score.” Age, antral follicle count, menstrual history, reproductive history, ultrasound findings, other hormones and the laboratory assay all matter.
Main evidence sources: MedlinePlus, American Society for Reproductive Medicine (ASRM), International Evidence-Based PCOS Guideline, Mayo Clinic Laboratories and assay-manufacturer documentation.
Important 2026 interpretation principle: There is no single universal AMH cutoff that defines “normal fertility,” diminished ovarian reserve or PCOS across every patient and every laboratory method. Population-, age- and assay-specific interpretation is preferred.
What Is AMH?
AMH stands for Anti-Müllerian Hormone. In the ovary, AMH is produced mainly by granulosa cells surrounding pre-antral and small antral follicles.
Because the number of these follicles generally decreases as ovarian reserve declines with age, circulating AMH also tends to decline across reproductive life.
AMH is therefore considered a useful marker of the quantity of the remaining follicular pool.
AMH reflects ovarian reserve mainly from a quantitative perspective. It does not directly measure the genetic or developmental quality of an individual egg.
A woman may have a low AMH and still conceive, while a woman with a high AMH is not guaranteed pregnancy.
Why Is an AMH Blood Test Ordered?
AMH testing is most useful when interpreted for a specific clinical reason rather than as an isolated “fertility check.”
Common uses include:
- Assessment of ovarian reserve during an infertility evaluation.
- Prediction of ovarian response before IVF or controlled ovarian stimulation.
- Helping fertility specialists select stimulation strategies.
- Evaluation of suspected diminished ovarian reserve.
- Assessment alongside antral follicle count.
- Selected evaluation of ovarian function after gonadotoxic therapy.
- Supporting assessment of polycystic ovarian morphology in appropriately selected adults.
- Occasionally monitoring selected ovarian granulosa-cell tumors under specialist care.
AMH is most useful when it answers a clearly defined clinical question.
Before Interpreting Your AMH Result
- Your age.
- Your exact AMH result and units.
- The laboratory's own reference interval.
- The assay or analyzer used, when available.
- Whether you currently use hormonal contraception.
- Your menstrual and fertility history.
- Whether an antral follicle count or other reproductive hormone tests are available.
Do not compare your result directly with another person's AMH value without checking age, units and laboratory method.
AMH Sample, Preparation and Fasting
| Laboratory factor | Practical information |
|---|---|
| Common specimen | Serum is commonly used. Some validated assays also accept specific plasma specimens. |
| Fasting | Usually not required specifically for AMH testing. |
| Time of day | No universally required collection time for routine AMH testing. |
| Menstrual cycle timing | AMH is less cycle-dependent than FSH or estradiol, although measurable variation across the cycle can occur. |
| Units | Commonly reported in ng/mL or pmol/L depending on laboratory and country. |
| Method | Usually an automated immunoassay in modern laboratories. |
MedlinePlus states that no special preparation is generally required for an AMH blood test.
Unlike early-follicular FSH, AMH can often be measured without restricting collection to cycle day 2 or 3. However, the modern PCOS guideline also recognizes that some menstrual-cycle variation can occur.
AMH Normal Range: Why There Is No Single Universal Number
One of the most common errors in AMH interpretation is using a single internet cutoff and applying it to every woman.
AMH concentrations depend strongly on:
- Age.
- Population.
- Analytical method.
- Assay calibration.
- Current or recent hormonal contraception.
- Ovarian surgery.
- Individual biological variation.
- Clinical indication for testing.
For this reason, the reference interval printed on the performing laboratory's report should be considered first.
AMH Age-Based Reference Values
The following table shows an example of age-specific female reference intervals published by Mayo Clinic Laboratories.
These values are provided for education and demonstrate how strongly AMH varies with age. They are not universal fertility cutoffs and should not replace the range supplied by your laboratory.
| Female age | Example AMH reference interval |
|---|---|
| 15–19 years | 0.62–7.8 ng/mL |
| 20–24 years | 1.2–12 ng/mL |
| 25–29 years | 0.89–9.9 ng/mL |
| 30–34 years | 0.58–8.1 ng/mL |
| 35–39 years | 0.15–7.5 ng/mL |
| 40–44 years | 0.03–5.5 ng/mL |
| 45–50 years | <2.6 ng/mL |
| 51–55 years | <0.88 ng/mL |
The ranges above are an example from Mayo Clinic Laboratories and are method/laboratory specific.
They should not be interpreted as universal thresholds for infertility, IVF success, PCOS or menopause.
AMH and Age
Age is essential when interpreting AMH.
AMH generally rises through adolescence and early adulthood, with population data suggesting a peak around the early 20s, and then progressively declines as reproductive age increases.
A result that appears relatively low for a 24-year-old may have a completely different clinical meaning in a 42-year-old.
This is why simply labeling AMH as “good” or “bad” without knowing age is poor laboratory interpretation.
What Does a Low AMH Mean?
A low AMH commonly suggests a reduced number of small recruitable ovarian follicles compared with what may be expected for age.
Possible contexts include:
- Normal age-related decline in ovarian reserve.
- Diminished ovarian reserve.
- Previous ovarian surgery.
- Previous chemotherapy or other gonadotoxic treatment.
- Primary ovarian insufficiency in an appropriate clinical context.
- Temporary or partial suppression associated with hormonal contraception.
- Individual biological variation.
It also does not prove infertility, and an extremely low result should not automatically be used to deny fertility treatment.
ASRM emphasizes that ovarian reserve markers such as AMH are much better at predicting oocyte yield and ovarian response during IVF than predicting whether a woman will achieve pregnancy naturally.
What Does a High AMH Mean?
Higher AMH generally reflects a larger pool of small follicles.
It may occur in:
- Younger women with relatively high ovarian reserve.
- Women with polycystic ovarian morphology.
- Some women with PCOS.
- Some patients who may show a stronger ovarian response to stimulation.
- Selected rare ovarian conditions such as granulosa-cell tumors.
A high AMH result should therefore not automatically be labeled as “excellent fertility.”
In fertility treatment, a higher AMH may predict a stronger ovarian response and greater oocyte yield, but excessive response can also be clinically important when planning stimulation.
AMH and Ovarian Reserve
Ovarian reserve refers broadly to the remaining pool of follicles capable of responding to gonadotropin stimulation.
Two of the most useful contemporary markers are:
- AMH — Anti-Müllerian Hormone.
- AFC — Antral Follicle Count.
AMH is particularly convenient because it can usually be measured at various points in the menstrual cycle and often declines before a clear rise in basal FSH is seen.
| Test | What it mainly reflects | Important limitation |
|---|---|---|
| AMH | Small follicle pool / ovarian reserve | Does not directly measure egg quality or natural pregnancy probability |
| AFC | Number of visible small antral follicles on ultrasound | Depends partly on ultrasound quality and operator assessment |
| FSH | Pituitary response to ovarian feedback | Cycle-day dependent and less sensitive to early reserve decline |
| Estradiol | Ovarian estrogen production | Should be interpreted with cycle timing and FSH |
Does AMH Measure Egg Quality?
No.
This distinction is fundamental.
AMH is primarily a marker of follicle quantity, not egg quality.
Age remains substantially more informative for the age-related decline in oocyte quality and chromosomal competence.
ASRM notes that AMH and AFC have only weak associations with qualitative reproductive outcomes such as egg quality, clinical pregnancy and live birth compared with their stronger ability to predict ovarian response and egg yield.
Can AMH Predict Natural Fertility?
Not reliably by itself.
A common misconception is that AMH can tell a woman exactly how fertile she is or how many reproductive years remain.
Research summarized by ASRM and ACOG shows that ovarian reserve testing performs poorly as a standalone predictor of natural conception in women without established infertility.
Therefore:
- A low AMH does not mean pregnancy is impossible.
- A high AMH does not guarantee pregnancy.
- AMH does not directly measure tubal function.
- AMH does not assess sperm factors.
- AMH does not directly evaluate implantation.
- AMH does not measure embryo chromosomal quality.
AMH and IVF Response
One of the strongest clinical uses of AMH is predicting ovarian response to stimulation during assisted reproduction.
In general:
| AMH pattern | Potential stimulation implication |
|---|---|
| Lower AMH | May be associated with fewer recruitable follicles and lower expected oocyte yield. |
| Intermediate AMH | May correspond to an expected or moderate ovarian response depending on age and AFC. |
| Higher AMH | May predict a higher follicular response and greater oocyte yield. |
Treatment decisions should not be based on AMH alone. Fertility specialists integrate age, AFC, previous stimulation response, body characteristics, diagnosis and other reproductive factors.
AMH and PCOS
AMH is frequently higher in women with PCOS because many individuals with PCOS have an increased number of small ovarian follicles capable of producing AMH.
However, the modern interpretation is more nuanced than simply stating that “high AMH means PCOS.”
In adults, serum AMH may be used within the diagnostic algorithm to help define polycystic ovarian morphology (PCOM).
However:
- AMH should not be used as a single standalone diagnostic test for PCOS.
- AMH is not required when irregular menstrual cycles and hyperandrogenism already establish the relevant diagnostic pathway.
- AMH should not currently be used for PCOS diagnosis in adolescents.
- Population- and assay-specific cutoffs should be used.
- Using both ultrasound and AMH solely to define PCOM may contribute to overdiagnosis.
When PCOS is suspected, clinicians may also evaluate androgen-related tests.
Related MedLab Academy guide: Testosterone Blood Test: High vs Low Testosterone and Laboratory Interpretation .
AMH Interpretation in a Possible PCOS Pattern
| Finding | Possible interpretation |
|---|---|
| Higher AMH alone | Insufficient to diagnose PCOS. |
| Higher AMH + irregular cycles | PCOS may enter the differential, but clinical evaluation remains necessary. |
| Higher AMH + biochemical/clinical hyperandrogenism | May strengthen an overall PCOS pattern depending on the diagnostic pathway. |
| Higher AMH in an adolescent | Should not be used as a diagnostic marker for PCOS under current international guidance. |
Hormonal Contraception and AMH
Hormonal contraception can suppress ovarian reserve markers in some women.
ASRM notes that prolonged hormonal contraceptive use may lower AMH and antral follicle count, meaning an unexpectedly low result during hormonal contraception should be interpreted cautiously.
Any decision to discontinue medication for fertility assessment should be made with the treating clinician.
In selected fertility evaluations, repeat ovarian reserve assessment after stopping hormonal contraception may be considered by the treating specialist when suppression is suspected.
Factors That Can Affect AMH Interpretation
| Factor | Possible effect or interpretation issue |
|---|---|
| Age | AMH generally declines with advancing reproductive age. |
| Hormonal contraception | May suppress AMH and AFC in some users. |
| Ovarian surgery | May reduce ovarian reserve depending on procedure and ovarian tissue affected. |
| PCOS / PCOM | Often associated with higher AMH. |
| BMI | Population studies suggest lower AMH may occur with higher BMI. |
| Menstrual cycle day | AMH is relatively stable compared with FSH, but variation may still occur. |
| Assay platform | Different AMH methods may produce different numerical results and reference intervals. |
| Chemotherapy / gonadotoxic therapy | May significantly reduce ovarian follicular reserve. |
Why an AMH Result May Be Misleading
An AMH result may be technically valid but clinically misleading if it is interpreted without context.
Common situations include:
- Comparing a result with an inappropriate age group.
- Using a reference interval from another laboratory.
- Comparing different assay platforms as if they were interchangeable.
- Ignoring current hormonal contraception.
- Assuming low AMH means infertility.
- Assuming high AMH means superior egg quality.
- Using AMH alone to diagnose PCOS.
- Using AMH alone to predict menopause timing.
AMH Laboratory Methods
Modern AMH testing is usually performed using automated immunoassays.
Examples include platforms from major manufacturers such as Roche and Beckman Coulter.
For example, Roche's Elecsys AMH assay uses an electrochemiluminescence immunoassay methodology and is validated for measurement in serum and selected plasma specimens.
Different AMH assays can differ in:
- Calibration.
- Analytical sensitivity.
- Measuring range.
- Reference intervals.
- Sample requirements.
- Interference characteristics.
When monitoring AMH over time, interpretation is strongest when results are compared using the same laboratory and analytical method whenever practical.
A numerical change after switching assay platforms should not automatically be interpreted as a true biological change.
Pre-Analytical Considerations
Compared with some endocrine tests, AMH has relatively convenient collection requirements, but laboratory quality remains important.
The laboratory should verify:
- Correct patient identification.
- Correct specimen type for the validated assay.
- Adequate sample volume.
- Appropriate collection tube.
- Acceptable specimen integrity.
- Proper transport and storage according to manufacturer requirements.
- Absence of assay-specific interference exceeding validated limits.
Grossly unsuitable specimens should be handled according to the laboratory's validated rejection criteria rather than applying a universal rule across all AMH platforms.
Analytical Quality and AMH Testing
Reliable AMH reporting requires routine laboratory quality practices including:
- Internal quality control.
- Calibration verification when required.
- External quality assessment or proficiency testing where available.
- Lot-to-lot review.
- Monitoring analytical precision.
- Validation of reference intervals or verification according to laboratory policy.
- Awareness of assay-specific limitations.
MedLab AMH Interpretation Matrix
| Pattern | Possible laboratory meaning | Useful context |
|---|---|---|
| Low AMH + low AFC | Supports reduced quantitative ovarian reserve | Age, fertility history, FSH, estradiol |
| Low AMH + normal AFC | Discordant reserve markers | Repeat/context may be useful; review assay and contraception |
| High AMH + high AFC | Larger follicle pool / possible PCOM pattern | Cycles, androgen status, PCOS criteria |
| High AMH + irregular cycles + androgen excess | Pattern may support evaluation for PCOS | Clinical diagnostic criteria remain essential |
| Low AMH during hormonal contraception | Possible biological suppression of reserve markers | Medication history and specialist interpretation |
| Very low AMH at older reproductive age | May reflect advanced decline in quantitative ovarian reserve | Age remains critical to fertility counseling |
AMH vs FSH
| Feature | AMH | FSH |
|---|---|---|
| Main role | Ovarian reserve marker | Pituitary gonadotropin reflecting ovarian feedback |
| Cycle timing | Relatively less dependent on cycle day | Basal assessment is usually cycle-timed |
| Early reserve decline | May decline before FSH rises | May remain normal during earlier reserve decline |
| Egg quality | Does not directly measure it | Does not directly measure it |
What Tests Are Commonly Interpreted With AMH?
Depending on the clinical question, AMH may be interpreted with:
- Antral follicle count.
- FSH.
- Estradiol.
- LH.
- Progesterone when ovulation assessment is relevant.
- Testosterone and other androgens when PCOS is suspected.
- Prolactin in selected menstrual or infertility investigations.
- TSH and thyroid testing.
- Metabolic tests in PCOS, such as glucose and HbA1c.
Related MedLab Academy guides:
Case Example 1: Low AMH in a Younger Woman
Example: A 29-year-old woman undergoing fertility evaluation has an AMH below the age-specific laboratory reference interval.
The result may suggest reduced quantitative ovarian reserve relative to age, but it should not be interpreted as proof that spontaneous pregnancy cannot occur.
Useful next information may include AFC, menstrual history, reproductive history and other fertility investigations.
Case Example 2: High AMH and Irregular Cycles
A 27-year-old woman has irregular menstrual cycles, biochemical androgen excess and an elevated AMH.
The high AMH may support a pattern of increased follicular number or PCOM, but it does not independently diagnose PCOS.
The complete diagnostic algorithm and exclusion of other causes remain necessary.
Case Example 3: Unexpectedly Low AMH During Hormonal Contraception
A 32-year-old woman taking long-term hormonal contraception has a lower-than-expected AMH.
Because hormonal contraception can suppress ovarian reserve markers in some women, the result should be interpreted cautiously.
If an accurate baseline assessment is clinically important, the fertility specialist may determine whether reassessment is appropriate.
The patient should not discontinue prescribed contraception solely because of an AMH result without medical guidance.
Can AMH Predict Menopause?
AMH declines toward very low or undetectable concentrations as ovarian follicular reserve becomes depleted.
However, predicting the exact age of menopause for an individual woman from one AMH measurement is not sufficiently precise for routine clinical use.
AMH should therefore not be marketed as a test that can tell someone exactly how many fertile years remain.
AMH and Primary Ovarian Insufficiency
Very low or undetectable AMH may be observed in women with markedly reduced ovarian reserve and in some cases of primary ovarian insufficiency.
However, AMH alone does not establish a diagnosis of primary ovarian insufficiency.
Clinical history, menstrual pattern and other hormonal investigations remain necessary.
AMH After Chemotherapy or Gonadotoxic Treatment
Chemotherapy and other gonadotoxic treatments can reduce the ovarian follicle pool and may lower AMH.
AMH can contribute useful information in selected fertility-preservation and post-treatment assessments, but the degree of recovery and future reproductive potential cannot be predicted from one result alone.
When Should AMH Be Repeated?
There is no universal schedule requiring routine AMH testing every few months.
Repeat testing may be considered when:
- The result does not fit the clinical picture.
- The initial result appears inconsistent with AFC.
- A different assay or laboratory was used and comparison is uncertain.
- Hormonal contraception may have affected interpretation.
- A fertility specialist needs an updated reserve assessment before treatment.
- There has been an important clinical event that may affect ovarian reserve.
AMH should not be repeatedly measured simply to watch the number rise or fall without a clinical reason.
AMH Trend Interpretation
A declining AMH over time may reflect biological ovarian aging, but trend interpretation has limitations.
Before deciding that a change is biologically meaningful, check:
- Was the same assay used?
- Was the same laboratory used?
- Was hormonal contraception started or stopped?
- Was there ovarian surgery or gonadotoxic therapy?
- Is the change larger than expected analytical and biological variation?
A change between two AMH values should therefore not automatically be interpreted as accelerated loss of fertility.
Abnormal AMH vs Critical AMH
AMH should not be managed like potassium, glucose or other tests that may have immediate life-threatening critical-result thresholds.
An AMH result can be clinically important while not representing an acute emergency.
Laboratories should not invent universal “critical AMH values” unless such thresholds are specifically established by their validated clinical policy.
When Should an AMH Result Be Discussed With a Healthcare Professional?
Professional interpretation is particularly useful when:
- AMH is unexpectedly low for age.
- AMH is unusually high and menstrual cycles are irregular.
- You are undergoing infertility evaluation.
- You are planning IVF or fertility preservation.
- You have had ovarian surgery.
- You are preparing for or have received gonadotoxic cancer therapy.
- You have possible symptoms or laboratory findings associated with PCOS.
- The AMH result conflicts with AFC or other reproductive tests.
An isolated abnormal AMH result is generally not a medical emergency, but its significance depends strongly on why the test was ordered.
MedLab Academy AMH Interpretation Card
| Result pattern | Think about | Do not assume |
|---|---|---|
| Low AMH | Age, AFC, ovarian reserve, contraception, ovarian history | Infertility is certain |
| Very low AMH | Markedly reduced reserve may be present | Pregnancy is impossible |
| High AMH | Larger follicle pool, PCOM/PCOS context | Egg quality is excellent |
| High AMH + androgen excess | Consider complete PCOS diagnostic picture | AMH alone diagnoses PCOS |
| Low AMH on hormonal contraception | Possible suppression of ovarian reserve markers | The measured value is necessarily the untreated baseline |
Common AMH Interpretation Mistakes
| Mistake | Better interpretation |
|---|---|
| Calling AMH an “egg quality test” | AMH mainly reflects quantitative ovarian reserve. |
| Using one cutoff for every age | Interpret AMH relative to age and assay. |
| Diagnosing infertility from low AMH | AMH alone does not predict natural conception accurately. |
| Diagnosing PCOS from high AMH alone | Use the accepted PCOS diagnostic algorithm. |
| Comparing results from different labs blindly | Check analytical method and reference interval. |
| Ignoring contraception | Hormonal contraception may suppress AMH in some women. |
| Assuming high AMH means guaranteed IVF success | AMH predicts ovarian response more strongly than pregnancy or live birth. |
Frequently Asked Questions
What is a good AMH level?
There is no single AMH value that defines “good fertility.” Interpretation depends on age, laboratory method, reference interval and the reason for testing.
Does low AMH mean infertility?
No. Low AMH generally indicates lower quantitative ovarian reserve, but it does not prove that natural pregnancy cannot occur.
Does high AMH mean PCOS?
No. High AMH can occur with PCOS or polycystic ovarian morphology, but AMH should not be used as a standalone diagnostic test.
Does AMH tell you egg quality?
No. AMH mainly reflects follicle quantity. Age is much more informative for age-related changes in oocyte quality.
Do I need to fast for an AMH blood test?
No special fasting preparation is generally required specifically for AMH testing.
What day of the menstrual cycle should AMH be tested?
AMH is relatively less dependent on menstrual-cycle timing than FSH and estradiol, so testing can often be performed on different cycle days. Some biological variation may still occur.
Can birth-control pills lower AMH?
Hormonal contraception can suppress AMH and AFC in some women, particularly with prolonged use, so results should be interpreted cautiously.
Can AMH predict IVF success?
AMH is useful for predicting ovarian response and expected oocyte yield, but it is much less powerful for predicting egg quality, pregnancy or live birth.
Can AMH predict menopause?
AMH declines toward menopause, but a single value cannot accurately predict the exact age of menopause for an individual woman.
Should AMH be repeated every year?
Routine repeated AMH testing is not automatically necessary. Repeat testing should have a defined clinical purpose.
Authoritative Sources and Evidence
- MedlinePlus — Anti-Müllerian Hormone Test
- American Society for Reproductive Medicine — Testing and Interpreting Measures of Ovarian Reserve
- ASRM — Hormonal Contraception and Ovarian Reserve Markers
- International Evidence-Based Guideline for PCOS — ASRM
- Mayo Clinic Laboratories — Anti-Müllerian Hormone, Serum
- American College of Obstetricians and Gynecologists — Use of AMH in Women Not Seeking Fertility Care
- Roche Diagnostics — Elecsys AMH Assay
MedLab Academy reviews laboratory interpretation against professional guidance, authoritative medical resources and assay-specific information. Reference intervals and diagnostic recommendations may change as methods and clinical guidance evolve.
Key Takeaways
- AMH is one of the most useful laboratory markers of quantitative ovarian reserve.
- AMH generally declines with reproductive aging.
- Low AMH does not equal infertility.
- High AMH does not guarantee fertility or superior egg quality.
- AMH is useful for predicting ovarian response during fertility treatment.
- AMH and AFC are among the most informative ovarian reserve markers.
- Current hormonal contraception may suppress ovarian reserve markers in some women.
- AMH may contribute to PCOS assessment in adults but should not diagnose PCOS by itself.
- PCOS interpretation requires assay- and population-specific considerations.
- AMH should not currently be used as a diagnostic marker for PCOS in adolescents.
- Age remains essential when interpreting AMH.
- Reference intervals differ between laboratories and assay platforms.
- AMH measures follicle quantity much more directly than egg quality.
MedLab Academy provides evidence-based educational information for laboratory professionals, students, healthcare learners and readers seeking to understand laboratory results.
This article does not provide an individual diagnosis, fertility prognosis or treatment recommendation. AMH results should be interpreted by an appropriately qualified healthcare professional together with age, reproductive history, symptoms, ultrasound findings, medications and other laboratory results.
Prepared by Omar Adwan
DHA-Licensed Medical Laboratory Technologist
Founder, MedLab Academy